AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?

Zacks analysis identifies Afya (AFYA) as the superior value investment compared to Grand Canyon Education (LOPE) within the Schools sector. AFYA boasts a Zacks Rank #1 (Strong Buy) and an 'A' Value grade, driven by a forward P/E of 8.99, PEG ratio of 0.50, and P/B of 1.79. These metrics significantly outperform LOPE's Zacks Rank #3 (Hold) and 'C' Value grade, indicating AFYA's more attractive valuation and improving earnings outlook for value-focused investors.

Analysis

A comparative analysis of two stocks in the education sector, Afya (AFYA) and Grand Canyon Education (LOPE), reveals a clear preference for AFYA from a value investing perspective. This conclusion is supported by the Zacks Rank system, where AFYA holds a #1 (Strong Buy) rating, indicative of positive earnings estimate revisions and an improving outlook, while LOPE is rated #3 (Hold). The valuation disparity is significant across multiple metrics. AFYA trades at a forward P/E ratio of 8.99, less than half of LOPE's 19.27. Furthermore, AFYA's PEG ratio of 0.50 suggests its stock price may be undervalued relative to its expected earnings growth, a stark contrast to LOPE's PEG of 1.28. The divergence is also evident in their price-to-book ratios, with AFYA at 1.79 versus LOPE's 6.14. Collectively, these quantitative factors earn AFYA a top-tier Value grade of 'A', while LOPE receives a 'C', reinforcing the assessment that AFYA presents a superior value proposition at current levels.

Key Decisions for Investors

• Investors with a value-oriented mandate should consider Afya (AFYA) due to its strong buy rating and superior valuation metrics, including a forward P/E of 8.99 and a PEG ratio of 0.50.
• Given Grand Canyon Education's (LOPE) 'Hold' rating, 'C' value grade, and significantly higher valuation multiples, investors may find more attractive risk-reward opportunities elsewhere in the sector.
• The core thesis for AFYA is its strong earnings outlook, so monitoring future earnings reports and analyst estimate revisions is critical to confirm the continuation of this trend.